situ hibridizasyon yöntemi i - Çukurova Üniversitesi

156. Pouryazdanparast P, Newman M, et al. Distinguishing epitheloid blue nevus from blue nevüslike
cutaneous melanoma metastazis using fluorescence in situ hybridization. Am J Surg Pathol.
2009; 33(9):1396-1400.
157. Gerami P, Wass A, Mafee M, et al. Fluorescence in situ hybridization for distinguishing nevoid
melanomas from mitotically active nevi. Am J Surg Pathol. 2009; 33 (12):1783-1788
158. Newman MD, Mirzabeigi M, at al. Chromosomal copy number changes supporting the
classification of lentiginous junctional melanoma of the elderly as a subtype of melanoma. Mod
Pathol. 2009; 22(9):1258-1262
159. Vergier B, at al. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic
tumors: European study of 113 cases (published online a head of print December 10, 2010; Mod
Pathol. Doi: 01038/modpathol.2010; 228)
160. Gaisher T, at al. Classifying ambiguous melanocytic lesions with FİSH and clinical long-term
follow-up. Mod Pathol. 2010; 23(3): 413-419.
161. Zimmermann A.K. at al, FİSH analysis for diagnostic evaluation of challenging melanocytic
lesions. Histol Histopathol 2010; 25: 1139-1147
162. Pedram Geramy, MD. at al. Sensitivity of Fluorescence In Situ Hybridization for Melanoma
Diagnosis Using RREB1,MYB, Cep6 ve 11q13 Probes in Melanoma Subtypes. Arch Dermathol.
2010; 146 (3):273-278.
163. Christine E. Fuller, MD; Arie Perry, MD. Fluorescence In Situ Hybridization (FISH) in
Diagnostic and Investigative Neuropathology Brain Pathol 2002;12:67-86
164. Prerana Jha, MSc, Chitra Sarkar, MD at al, Detection of Allelic Status of 1p and 19q by
Microsatellite-based PCR Versus FISH Limitations and Advantages in Application to Patient
Management, Diagn Mol Pathol 2011; 20: 40–47
165. Jeffrey P. North at al, Assessment of Copy Number Status of Chromosomes 6 and 11 by FISH
Provides Independent Prognostic Information in Primary Melanoma Am J Surg Pathol 2011; 35:
1146–1150
166. Diamond, M Mabry, D W Ball, S B Baylin and B D Nelkin A Thiagalingam, A De Bustros, M
Borges, R Jasti, D Compton, L medullary thyroid carcinomas.in the differentiation response to
Ras in human Mol. Cell. Biol 1996; 16(10):5335
167. Gda C Santos, M Zielenska, M Prasad, J A Squire Chromosome 6p amplification and cancer
progression J Clin Pathol 2007; 60: 1–7.
168. Keiran S.M. Smalley at al, cyclin D1 expression can mediate BRAF inhibitör resistance in BRAF
V600E–mutated melanomas, Mol Cancer Ther. 2008 September; 7(9): 2876–2883.
103